Study on Ketamine vs Fentanyl for Pain Management in Laparoscopic Cholecystectomy
This clinical trial could significantly impact postoperative pain management protocols, potentially favoring ketamine over traditional analgesics like fentanyl. A shift in clinical practice could alter market dynamics and influence the competitive landscape for pain management solutions.
Phase III
Anesthesia / Pain Management
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
This clinical trial could significantly impact postoperative pain management protocols, potentially favoring ketamine over traditional analgesics like fentanyl. A shift in clinical practice could alter market dynamics and influence the competitive landscape for pain management solutions.
Why it matters
This clinical trial could significantly impact postoperative pain management protocols, potentially favoring ketamine over traditional analgesics like fentanyl. A shift in clinical practice could alter market dynamics and influence the competitive landscape for pain management solutions.
What changed
Trial Update
Analysis
A randomized double-blind study is comparing intraperitoneal ketamine and fentanyl as adjuvants to bupivacaine for postoperative pain control in laparoscopic cholecystectomy.
This clinical trial could significantly impact postoperative pain management protocols, potentially favoring ketamine over traditional analgesics like fentanyl. A shift in clinical practice could alter market dynamics and influence the competitive landscape for pain management solutions.
Monitor results of the trial for efficacy data and subsequent changes in clinical guidelines for postoperative pain management.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.